GET THE APP

..

Journal of AIDS & Clinical Research

ISSN: 2155-6113

Open Access

Volume 15, Issue 3 (2024)

Mini Review Pages: 1 - 2

Pharmacokinetics and Pharmacodynamics of Novel Nucleoside Reverse Transcriptase Inhibitors

Josefa Antonia*

DOI: 10.37421/2155-6113.2024.15.1003

Nucleoside reverse transcriptase inhibitors (NRTIs) are cornerstone antiretroviral drugs used in the treatment of HIV/AIDS. The advent of novel NRTIs has expanded therapeutic options, offering improved efficacy and safety profiles. This article explores the pharmacokinetics and pharmacodynamics of these novel NRTIs, emphasizing their absorption, distribution, metabolism and excretion (ADME) properties, as well as their mechanisms of action, resistance profiles and clinical implications.

Mini Review Pages: 1 - 2

Challenges and Opportunities in Implementing Pre-Exposure Prophylaxis (PrEP) Programs

Dolores José*

DOI: 10.37421/2155-6113.2024.15.1004

Implementing Pre-Exposure Prophylaxis (PrEP) programs presents both challenges and opportunities in public health. Challenges include access barriers, stigma, adherence issues and cost. However, effective implementation offers significant opportunities to reduce HIV transmission rates, improve health equity and empower at-risk populations through education and support. This abstract explores these dynamics, highlighting the critical factors influencing successful PrEP program implementation.

Mini Review Pages: 1 - 2

Clinical Applications of Long-acting Antiretrovirals in HIV/AIDS Care

María Carmen*

DOI: 10.37421/2155-6113.2024.15.1005

The advent of long-acting antiretroviral therapies (LA-ARTs) has revolutionized HIV/AIDS management by addressing adherence challenges associated with daily medication regimens. LA-ARTs offer sustained drug levels, reducing dosing frequency to weekly or monthly intervals. This review explores the clinical implications and applications of LA-ARTs in HIV/AIDS care, emphasizing their impact on treatment adherence, viral suppression and quality of life. Key studies demonstrate comparable efficacy to daily regimens with potential benefits in resource-limited settings and among marginalized populations. Challenges such as safety profiles, patient acceptance and healthcare infrastructure requirements are also discussed. As LA-ARTs continue to evolve, their integration into global HIV/AIDS treatment strategies holds promise for improving long-term outcomes and reducing transmission rates.

Google Scholar citation report
Citations: 5061

Journal of AIDS & Clinical Research received 5061 citations as per Google Scholar report

Journal of AIDS & Clinical Research peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward